
Immuneering Corp
IMRXNasdaqCIK 1790340HealthcareFiscal year ends Dec 31
Reports and events: 79 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-06-1416:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001790340-23-000025 |
| 2023-05-0416:04 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001790340-23-000023 |
| 2023-05-0416:03 ET | 8-K | 9.01 Financial statements and exhibits | 0001790340-23-000022 |
| 2023-05-0107:28 ET | DEF 14A | Proxy statementPeriod 2023-05-01 | 0001790340-23-000011 |
| 2023-04-1916:07 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-047191 |
| 2023-04-1809:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-046455 |
| 2023-03-0616:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-002905 |
| 2023-03-0616:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-002901 |
| 2022-11-1009:05 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-017304 |
| 2022-11-1009:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-017302 |
| 2022-09-1916:30 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-22-101186 |
| 2022-08-1016:09 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013063 |
| 2022-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-013057 |
| 2022-07-2507:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-082207 |
| 2022-06-2416:06 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-074300 |
| 2022-05-1006:36 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-007953 |
| 2022-05-1006:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-007951 |
| 2022-05-0207:01 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001104659-22-054083 |
| 2022-03-1006:38 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-003208 |
| 2022-03-1006:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-003205 |
| 2022-01-1806:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-004651 |
| 2021-12-2206:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-152368 |
| 2021-11-0906:36 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-015147 |
| 2021-11-0906:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-015144 |
| 2021-09-0906:41 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-012336 |
| 2021-09-0906:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-012334 |
| 2021-07-2807:40 ET | S-1/A | Registration statement, amended | 0001104659-21-096615 |
| 2021-07-2606:03 ET | S-1/A | Registration statement, amended | 0001104659-21-095557 |
| 2021-07-0916:02 ET | S-1 | Registration statement | 0001104659-21-090635 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 03:06 ET. Listed shows no prices and gives no investment advice.